Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis

NCT01830699 is registered in ClinicalTrials.gov with Keesler Air Force Base Medical Center as lead sponsor.

NCT NCT01830699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
Lead sponsor
Keesler Air Force Base Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2013
Completion date
March 31, 2014
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subacromial bursitis